Related Experiment Video
Updated: Jun 8, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
A role for coding functional variants in HNF4A in type 2 diabetes susceptibility
B Jafar-Mohammadi1, C J Groves, A P Gjesing
1Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Headington, UK.
The HNF4A gene variant T130I shows a modest association with type 2 diabetes risk. While V255M showed no link, T130I warrants further investigation for its role in diabetes susceptibility.
Area of Science:
- Genetics
- Endocrinology
- Metabolic Diseases
Background:
- Rare mutations in HNF4A cause MODY, and common variants may contribute to multifactorial diabetes.
- Two HNF4A variants, V255M and T130I, influence gene expression and are investigated for type 2 diabetes association.
Purpose of the Study:
- To evaluate the contribution of HNF4A variants V255M and T130I to type 2 diabetes susceptibility.
- To conduct a large-scale association analysis of these variants in diverse populations.
Main Methods:
- Genotyping of V255M and T130I in over 5,745 cases and 14,756 controls from the UK and Denmark.
- Expanded association analysis including additional European and Canadian cohorts.
- Meta-analysis of T130I association studies with up to 14,279 cases and 26,835 controls.
Main Results:
- No significant association was found between the V255M variant and type 2 diabetes.
- The T130I variant showed a modest association with type 2 diabetes in UK and Danish samples (OR 1.17, p=1.5×10⁻⁴).
- Meta-analysis strengthened the association for T130I (OR 1.20, p=2.1×10⁻⁵), though not reaching genome-wide significance.
Conclusions:
- The low-frequency T130I variant in HNF4A may influence type 2 diabetes risk.
- The association for T130I requires further validation against stringent significance thresholds.
- This study highlights challenges in the genetic association testing of low-frequency variants in complex diseases.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
Related Concept Videos
Type II Diabetes I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Type I Diabetes I: Introduction
Pharmacogenomics: Identification of New Drug Targets